Update on trends in varicella mortality during the varicella vaccine era-United States, 1990-2016

We reported previously that the annual average mortality rate in the United States in 2008-2011 for varicella listed as the underlying cause declined 87% compared with the prevaccine period (1990-1994). Here, we update the analysis with five additional years of data. We used varicella death data fro...

Full description

Saved in:
Bibliographic Details
Published inHuman vaccines & immunotherapeutics Vol. 14; no. 10; pp. 2460 - 2463
Main Authors Leung, Jessica, Marin, Mona
Format Journal Article
LanguageEnglish
Published United States Taylor & Francis 03.10.2018
Taylor & Francis Group
Subjects
cdc
nchs
Short Report
surveillance
vaccine-preventable disease
varicella deaths
varicella mortality
varicella vaccine
vzv
varicella vaccine
CDC
VZV
NCHS
vaccine-preventable disease
varicella mortality
varicella deaths
surveillance
Online AccessGet full text

Cover

More Information
Summary:We reported previously that the annual average mortality rate in the United States in 2008-2011 for varicella listed as the underlying cause declined 87% compared with the prevaccine period (1990-1994). Here, we update the analysis with five additional years of data. We used varicella death data from the 2012-2016 Mortality Multiple Cause-of Death records to calculate mortality rates during 2012-2016 and trends since the prevaccine period and end of 1-dose vaccination program (2005-2007). The annual average age-adjusted mortality rate for varicella as the underlying cause was 0.03 per million population during 2012-2016, a 94% reduction from prevaccine years and a 47% reduction from 2005-2007. Varicella deaths continue to decline due to the varicella vaccination program in the United States.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2164-5515
2164-554X
DOI:10.1080/21645515.2018.1480283